Kathryn McMenimen, Clare Boothe Luce Assistant Professor of Chemistry at Mount Holyoke College, was part of a research team that discovered a new possible treatment for cataracts.
Cataracts are considered a “priority eye disease” by the World Health Organization, and are responsible for more than 20 million cases of blindness in the world.
The research team identified a molecule capable of dissolving the protein clusters that cause cataracts. What’s more, the molecule could be suspended in eye drops. Previously, surgery had been the only option, putting treatment financially out of reach for many of those affected.
The research may have further implications for neurodegenerative disorders, including Alzheimer’s, Parkinson’s and Huntington’s diseases.
Read in-depth coverage from the University of California San Francisco here.